Boccia R - Search Results

1

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.

Bendell JC, Zakari A, Peyton JD, Boccia R, Moskowitz M, Gian V, Lipman A, Waterhouse D, LoCicero R, Earwood C, Lane CM, Meluch A. Bendell JC, et al. Among authors: boccia r. Oncologist. 2016 Mar;21(3):279-80. doi: 10.1634/theoncologist.2015-0439. Epub 2016 Feb 24. Oncologist. 2016. PMID: 26911408 Free PMC article. Clinical Trial.

2

Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia.

Boccia R, Malik IA, Raja V, Kahanic S, Liu R, Lillie T, Tomita D, Clowney B, Silberstein P. Boccia R, et al. Oncologist. 2006 Apr;11(4):409-17. doi: 10.1634/theoncologist.11-4-409. Oncologist. 2006. PMID: 16614237 Free article.

3

The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia.

Boccia R, Lillie T, Tomita D, Balducci L. Boccia R, et al. Oncologist. 2007 May;12(5):584-93. doi: 10.1634/theoncologist.12-5-584. Oncologist. 2007. PMID: 17522247 Free article. Clinical Trial.

4

A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer.

Boccia RV, Cosgriff TM, Headley DL, Badarinath S, Dakhil SR. Boccia RV, et al. Clin Colorectal Cancer. 2010 Apr;9(2):102-7. doi: 10.3816/CCC.2010.n.014. Clin Colorectal Cancer. 2010. PMID: 20378504 Clinical Trial.

5

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

Hainsworth JD, Rubin MS, Spigel DR, Boccia RV, Raby S, Quinn R, Greco FA. Hainsworth JD, et al. Among authors: boccia rv. J Clin Oncol. 2013 Jan 10;31(2):217-23. doi: 10.1200/JCO.2012.43.3755. Epub 2012 Oct 1. J Clin Oncol. 2013. PMID: 23032625 Clinical Trial.

6

Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.

Garcia-Manero G, Montalban-Bravo G, Berdeja JG, Abaza Y, Jabbour E, Essell J, Lyons RM, Ravandi F, Maris M, Heller B, DeZern AE, Babu S, Wright D, Anz B, Boccia R, Komrokji RS, Kuriakose P, Reeves J, Sekeres MA, Kantarjian HM, Ghalie R, Roboz GJ. Garcia-Manero G, et al. Among authors: boccia r. Cancer. 2017 May 15;123(6):994-1002. doi: 10.1002/cncr.30533. Epub 2017 Jan 17. Cancer. 2017. PMID: 28094841 Free PMC article. Clinical Trial.

7

Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.

Berdeja JG, Bauer T, Arrowsmith E, Essell J, Murphy P, Reeves JA Jr, Boccia RV, Donnellan W, Flinn I. Berdeja JG, et al. Br J Haematol. 2017 Apr;177(2):254-262. doi: 10.1111/bjh.14536. Epub 2017 Feb 7. Br J Haematol. 2017. PMID: 28169430 Free article. Clinical Trial.

8

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.

Flinn IW, Thompson DS, Boccia RV, Miletello G, Lipman A, Flora D, Cuevas D, Papish SW, Berdeja JG. Flinn IW, et al. Br J Haematol. 2018 Feb;180(3):365-373. doi: 10.1111/bjh.15044. Epub 2017 Nov 28. Br J Haematol. 2018. PMID: 29193021 Free article. Clinical Trial.

9

Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).

Hainsworth JD, Waterhouse DM, Shih KC, Boccia RV, Priego VM, McCleod MJ, Kudrik FJ, Mitchell RB, Burris HA 3rd, Greco FA, Spigel DR. Hainsworth JD, et al. Among authors: boccia rv. Lung Cancer. 2018 Apr;118:6-12. doi: 10.1016/j.lungcan.2018.01.009. Epub 2018 Jan 31. Lung Cancer. 2018. PMID: 29572004 Clinical Trial.

10

A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma.

Hainsworth JD, Infante JR, Spigel DR, Arrowsmith ER, Boccia RV, Burris HA. Hainsworth JD, et al. Among authors: boccia rv. Cancer Invest. 2011 Aug;29(7):451-5. doi: 10.3109/07357907.2011.590568. Epub 2011 Jun 22. Cancer Invest. 2011. PMID: 21696296 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page